Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: ESTG - developer of non-invasive medical devices

No earlier versions found for this Subject.

Return to ESTG - developer of non-invasive medical devices

ELAST TECHNOLOGIES (OTC BB:ESTG.OB)

Company is on the fast track with several high tech. Medical devices.

Market Capitalization $12.9M
Shares Outstanding 7.96M
Float 3.50M

elast.com

ELAST Technologies, Inc., is developing a non-invasive, scientifically proven medical diagnostic tool designed to accurately diagnose allergies, as well as food and chemical sensitivities: the Electronic Allergo-Sensitivity Test Device. [The ELAST Device?]

ELAST Technologies to Merge With Bioelectronics Corp.
LAS VEGAS--(BUSINESS WIRE)--April 14, 2000--ELAST Technologies, Inc., (OTC BB:ESTG - news) www.elast.com announced that it has entered into a merger agreement with Maryland based Bioelectronics Corp. The merger brings together two companies that employ cutting edge electronic technology to address bio-electric medical needs. The potential market for their products, which includes all allergy sufferers and individuals with traumatic injuries, exceeds $11 billion dollars.

Bioelectronics Corp., a privately held research and development company based in Maryland, designs low cost and disposable magnetic field medical devices to accelerate and improve the quality of tissue healing. The Company's first product is its patented Portic Electronic Bandage, an inexpensive, disposable and self-contained radio frequency emitting device that hastens the healing of soft and hard tissue wounds including fresh fractures by 20-30%.